# InspireMD (NSPR) — Earnings

NSPR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nspr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.17 |
| EPS estimate | −$0.20 |
| EPS surprise | +15.00% |
| Revenue surprise | +28.05% |
| Revenue | $1.8M |
| Revenue estimate | $1.4M |
| Reported | Aug 14, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1433607/000149315226038438/form10-q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/be3f5cc0-dae7-df7e-259d-ae6acf071034.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 14, 2026 | −$0.20 | −$0.17 | 15.00% | $1.4M | $1.8M |
| Q1 2026 | May 4, 2026 | −$0.18 | −$0.16 | 11.11% | $2.7M | $3.4M |
| Q4 2025 | Mar 18, 2026 | −$0.19 | −$0.14 | 27.57% | $2.6M | $3.1M |
| Q3 2025 | Nov 4, 2025 | −$0.20 | −$0.17 | 12.82% | $1.8M | $2.5M |
| Q2 2025 | Aug 4, 2025 | −$0.26 | −$0.26 | 0.00% | $1.5M | $1.8M |
| Q1 2025 | May 8, 2025 | −$0.20 | −$0.22 | -10.00% | $1.5M | $1.5M |
| Q4 2024 | Mar 12, 2025 | −$0.20 | −$0.19 | 2.56% | $1.8M | $1.9M |
| Q3 2024 | Nov 12, 2024 | −$0.20 | −$0.16 | 20.00% | $1.7M | $1.8M |
| Q2 2024 | Aug 5, 2024 | −$0.19 | −$0.22 | -15.79% | $1.7M | $1.7M |
| Q1 2024 | May 13, 2024 | −$0.18 | −$0.21 | -16.67% | $2.0M | $1.5M |
| Q4 2023 | Mar 5, 2024 | −$0.19 | −$0.16 | 15.79% | $1.6M | $1.8M |
| Q3 2023 | Nov 6, 2023 | −$0.14 | −$0.15 | -7.14% | $1.5M | $1.6M |
| Q1 2023 | May 15, 2023 | −$0.68 | −$0.53 | 22.06% | $1.0M | $1.2M |
| Q4 2022 | Mar 30, 2023 | −$0.84 | −$0.60 | 28.57% | $1.0M | $1.0M |
| Q3 2020 | Nov 9, 2020 | −$1.20 | −$0.90 | 25.00% | $600,000.00 | $980,000.00 |
| Q2 2020 | Aug 5, 2020 | −$5.25 | −$3.00 | 42.86% | $200,000.00 | $313,000.00 |

## Frequently Asked Questions

### When did InspireMD (NSPR) last report earnings?

InspireMD last reported on Aug 14, 2026, covering fiscal Q2 2026.

### Did NSPR beat earnings estimates?

Yes. InspireMD reported EPS of −$0.17 for Q2 2026 against a −$0.20 estimate — a 15.00% beat.

### How much revenue did NSPR report last quarter?

InspireMD reported $1.8M in revenue for Q2 2026, against a consensus estimate of $1.4M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).